Atamparib in Patients With Advanced Solid Tumors
Clinical trial NCT07374419 · RECRUITING
Trial details
- NCT number
- NCT07374419
- Sponsor
- Nerviano Medical Sciences (Shanghai) Ltd.
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-03-18
- Primary completion
- 2028-07-31
- Enrollment
- 178
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.